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Female mouse embryonic stem cells (mESCs) contain two active X chromosomes, with one undergoing
random inactivation upon differentiation. Schulz et al. (2014) nowdemonstrate that the presence of two active
X chromosomes in mESCs prevents exit from pluripotency by blocking MAPK signaling, ensuring synchro-
nization between X chromosome dosage compensation and development.X chromosome inactivation (XCI) ensures
equal X chromosome gene dosage be-
tween males and females. In early preim-
plantation development of the female
mouse embryo, XCI initially occurs in
an imprinted manner, with inactivation of
the paternal X chromosome. Around the
time of implantation, the paternal X chro-
mosome is reactivated in the inner cell
mass, which contains the cells that will
develop into the embryo. mESCs derived
from embryos at this stage of develop-
ment contain two active X chromosomes
(XaXa). A few days later in development,
a subset of cells from the inner cell mass
become the epiblast, in which Xist is ex-
pressed and random XCI has occurred
(XaXi); in vitro, these cells are represented
by epiblast stem cells (reviewed in Less-
ing et al., 2013).
In vivo, the persistence of two active
X chromosomes following implantation
results in embryonic death (Takagi and
Abe, 1990). Therefore, proper XCI is
required for normal development. It has
been thought that the primary mechanism
responsible for the temporal linkage be-
tween differentiation and XCI is repres-
sion of Xist expression by pluripotency
factors, such as Oct4, Nanog, Sox2, and
Rex1 (Augui et al., 2011; Navarro et al.,
2008). However, this model does not
sufficiently account for the observation
that in many species, the development
of female embryos around the time of im-
plantation is slower than that of males
(Mittwoch, 1993). In their current study,
Heard and colleagues investigate alterna-
tive explanations for the temporal associ-
ation between XCI and differentiation anddiscover that rather than being a passive
consequence of differentiation, XCI plays
an active role in allowing exit from ground
state pluripotency in female cells.
To investigate the possibility that the
XaXa state may block differentiation,
Schulz et al. (2014) used an in vitro model
consisting of XX, XO, and XY mESC lines
undergoing differentiation from the naive
(or ground) pluripotent state to the primed
epiblast-like state. By examining serial
transcriptome profiles of these lines after
induction of differentiation, they demon-
strated that the presence of two active
X chromosomes was associated with
delayed exit from the ground state.
The authors then focused on identifying
the pathways through which the presence
of a second active X chromosome acts
to block differentiation. In mESCs, it has
been discovered that the MAPK/Mek
andGsk3 pathways destabilize the plurip-
otent state and therefore promote differ-
entiation, whereas Lif/Stat3 and Pi3K/Akt
signaling are necessary for maintaining
pluripotency. By comparing the gene
expression of targets of these path-
ways in XX, XO, and XY mESCs, Schulz
et al. showed that a double dose of the
X chromosome inhibits the MAPK/Mek
and Gsk pathways, stimulates the Akt
pathway, and has no effect on Stat
signaling. They further linked inhibition of
MAPK/Mek with reduced expression of
the de novo methyltransferases Dnmt3a/
b and showed that autosomal genes that
displayed differential expression in XX
mESCs compared to XO and XY mESCs
were more likely to be regulated by DNA
methylation.Cell Stem Cell 14These experiments present strong cir-
cumstantial evidence that the double
dose of the X chromosome in female cells
blocks the transition from the naive to the
primed state at least in part through
repression of MAPK/Mek and subsequent
reduction of Dnmt3a/b expression. To
better demonstrate a cause-and-effect
relationship between XCI and release
from a block to differentiation, the au-
thors forced expression of Xist in female
mESCs. Forced Xist expression from
one of the X chromosomes resulted in
XCI in a majority of cells, decreased
expression of three out of six pluripo-
tency-associated genes that had previ-
ously showed delayed downregulation
during differentiation of female mESCs,
increased global methylation levels, and
reduced Mek phosphorylation levels.
There is good experimental evidence
that the pluripotency factors Oct4, Sox2,
and Nanog repress Xist, at least in murine
cells (Navarro et al., 2008). These earlier
findings have led to the view that during
differentiation of female mESCs, a drop
in pluripotency factors results in derepres-
sion of Xist expression, resulting in XCI.
How do we interpret the results from
the current report, which indicate that
two active X chromosomes impede the
downregulation of a subset of pluripo-
tency-associated genes, partly through
repression of MAPK/Mek and conse-
quent decreases in expression of the
de novo DNA methyltransferases, in the
context of these earlier results? The initial
decrease in the level of pluripotency
factors in Schulz et al. is consistent with
a model in which an initial trigger for, February 6, 2014 ª2014 Elsevier Inc. 131
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Figure 1. Factors Regulating the Maintenance of the XaXa State and the Transition to the XaXi State
In this model, an initial signal to differentiate causes XaXa cells to downregulate pluripotency factors, which in turn derepress Xist, resulting in XCI and the inac-
tivation of one of the two X chromosomes. The loss of the double dose of the X chromosome leads to derepression of MAPK and Gsk signaling and repression of
Akt. MAPK signaling triggers an increase in the expression of Dnmt3a/b, which further represses pluripotency factors through DNA hypermethylation.
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an early, mild decrease in pluripotency
factors, thus allowing Xist expression.
This Xist expression results in inactivation
of one of the X chromosomes, which in
turn derepresses MAPK signaling, either
directly or indirectly. One of the effects of
MAPK signaling appears to be increased
expression of de novo DNA methyltrans-
ferase expression, which leads to DNA
methylation and further repression of plu-
ripotency factors, allowing exit from the
naive pluripotent state (Figure 1).
Studies of early mammalian develop-
ment are intrinsically challenging given
the small numbers and heterogeneity
of available cells. The differentiation of
ESCs is frequently used to model early
development, but such in vitro work is
vulnerable to experimental differences
between studies and discrepancies be-
tween in vitro and in vivo events (reviewed
in Wutz, 2012). Further complicating
studies on XCI in model organism sys-
tems is the fact that there is poor con-
servation of the regulatory sequences
surrounding the Xist gene, and that the
timing and patterns of Xist expression
and XCI differ widely between species
(Escamilla-Del-Arenal et al., 2011).
(Gafni et al., 2013) recently reported
in vitro culture conditions that facilitate
the derivation and culture of naive human132 Cell Stem Cell 14, February 6, 2014 ª201pluripotent stem cells (hPSCs). It will be
interesting to see if a similar mechanism
in humans promotes coupling of X chro-
mosome dosage with transition from the
ground state to the primed state. Funda-
mental work remains to be done in the
human system; for example, it has yet to
be shown whether female naive hPSCs
undergo random XCI with differentiation.
This is an important point because it has
been observed that hPSCs cultured in
standard conditions frequently lose XIST
expression and XCI. When these cells
are differentiated, proper XCI is not rees-
tablished (Nazor et al., 2012). It is inter-
esting to speculate whether the partial
loss of XCI seen in many hPSC cul-
tures has implications for the efficiency,
completeness, or stability of differentia-
tion of these cultures and whether or not
this loss can be attributed to stresses
associated with in vitro culture and there-
fore might be eliminated by development
of improved culture conditions (Wutz,
2012).
Finally, the specific loci on the X chro-
mosome responsible, at least in part, for
the block in differentiation remain to be
identified. The authors discuss a number
of pluripotency-associated genes on the
X chromosome and conclude that none
of them are likely to mediate repression
of MAPK signaling. These yet to be4 Elsevier Inc.discovered loci may act directly or indi-
rectly and may be coding genes, genes
for noncoding RNAs, sequences that
sequester protein or RNA factors, or se-
quences that affect topology or nuclear
localization. So the search continues.
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